FDA To Share Nanotoxicology Information

According to this FDA Law Blog post, Nanotech Update: FDA Enters Into MOU With Air Force Research Laboratory to Facilitate Sharing of Nanotoxicology Information, "FDA’s National Center for Toxicological Research (“NCTR”) has entered into a Memorandum of Understanding (“MOU”) that provides for the sharing of nanotoxicology information with the Air Force Research Laboratory, 711 Human Performance Wing, Human Effectiveness Directorate, Biosciences and Protection Division (“AFRL”). " 

Previous Posts: Hidden Health and Financial Liabilities of Nanotechnology Should The FDA Oversee Nanotechnology Dietary Supplements? 

Return Home: http://drughealth.blogspot.com/ 

Are Nanoparticles Dangerous Like Asbestos?

• Respected FDA cGMP online training programs, courses, and classes by SkillsPlus International Inc.

Updated October 15, 2022:

You might also be interested in:

GUIDANCE DOCUMENT - Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry - APRIL 2022 - FDA.gov

---  the original post follows well below  ---

Updated January 9, 2021

Speaking of nanoparticles, you might also be interested in:

Fact check: Lipid nanoparticles in a COVID-19 vaccine are there to transport RNA molecules - Reuters

- - -  original post follows below  - - -

More recent news buzz on the topic recently. When I see nanotechnology, or nanoparticles, I'm worrying about whether we're creating a wave of manmade asbestos-like materials and ensuing mesothelioma. I stumbled across this on the NIOSH site, and think you'll find it an interesting read. Coming from NIOSH, I'm more likely to believe what I read, "Approaches to Safe Nanotechnology - Managing the Health and Safety Concerns Associated with Engineered Nanomaterials." The document reviews what is currently known about nanoparticle toxicity, process emissions and exposure assessment, engineering controls, and personal protective equipment. This updated version of the document incorporates some of the latest results of NIOSH research, but it is only a starting point. The document serves a dual purpose: it is a summary of NIOSH's current thinking and interim recommendations; and it is a request from NIOSH to occupational safety and health practitioners, researchers, product innovators and manufacturers, employers, workers, interest group members, and the general public to exchange information that will ensure that no worker suffers material impairment of safety or health as nanotechnology develops. 

Return Home: http://drughealth.blogspot.com/ 

FDA Collaborates On Nanotech Initiative

The U.S. Food and Drug Administration today unveiled a new collaboration initiative with the Houston-based Alliance for NanoHealth (ANH) and its eight member institutions to help speed development of safe and effective medical products in the emerging field of nanotechnology. I'm glad to see this. Until nanotechnologies are better and more deeply understood, it makes sense to me that the best minds thinking about nanotech are collaborating. More FDA Information: FDA and Eight Academic and Research Institutions to Collaborate Under Nanotechnology Initiative - Overarching goal: developing an efficient pathway for safe and effective nanoengineered medical products 

Related Posts: Should The FDA Oversee Nanotechnology Dietary Supplements? Go For Gold - I Mean Nanoparticles And Drugs FDA - FAQs About Combination Products 

Return Home: http://drughealth.blogspot.com/